2002
DOI: 10.1002/jso.10082
|View full text |Cite
|
Sign up to set email alerts
|

Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long‐term prognosis

Abstract: CD44v6 protein may have an important role in hematogenous metastasis, and may be a biologic marker of prognostic significance in differentiated type gastric cancers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
27
0
2

Year Published

2004
2004
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 17 publications
2
27
0
2
Order By: Relevance
“…Its structure and function FIGURE 2: Kaplan-Meier survival curve for the patients with gastric cardia adenocarcinoma according to whether they were positive (n = 15) or negative (n = 27) for lymph node micrometastasis (LNM); the between-group 2-year survival rate differed significantly (63.6% versus 95.6%, P = 0.011) CD44v6 has been shown to be related to disease progression, lymph node metastasis and prognosis in gastric carcinoma. 17,18 In the present study, micrometastasis indicated by the presence of CK19 with or without CD44v6 was seen in 33 lymph nodes (9.5%) from 15 patients (33.3%); this is consistent with the results of Yun et al 10 We found that lymph node micrometastasis was correlated with the depth of invasion and Lauren classification: the micrometastasis rate was much higher in diffuse than in intestinal cancers. This finding may be explained by the association of an Ecadherin gene mutation with diffuse-type gastric cancer, which results in decreased cell adhesion and easily separated and aggressive tumour cells.…”
Section: Discussionsupporting
confidence: 92%
“…Its structure and function FIGURE 2: Kaplan-Meier survival curve for the patients with gastric cardia adenocarcinoma according to whether they were positive (n = 15) or negative (n = 27) for lymph node micrometastasis (LNM); the between-group 2-year survival rate differed significantly (63.6% versus 95.6%, P = 0.011) CD44v6 has been shown to be related to disease progression, lymph node metastasis and prognosis in gastric carcinoma. 17,18 In the present study, micrometastasis indicated by the presence of CK19 with or without CD44v6 was seen in 33 lymph nodes (9.5%) from 15 patients (33.3%); this is consistent with the results of Yun et al 10 We found that lymph node micrometastasis was correlated with the depth of invasion and Lauren classification: the micrometastasis rate was much higher in diffuse than in intestinal cancers. This finding may be explained by the association of an Ecadherin gene mutation with diffuse-type gastric cancer, which results in decreased cell adhesion and easily separated and aggressive tumour cells.…”
Section: Discussionsupporting
confidence: 92%
“…The results showed that the expression rate of CD44 in tumoral tissue reached 65% in contrast to no expression of this molecule in the adjacent normal mucosa. CD44 was more commonly expressed in the intestinal-type tumor than in diffusetype tumor, indicating that CD44 expression was related to the histological subtype of tumor, which is in agreement with previous studies [15,16] . In addition, a correlation was found between CD44 expression and tumor grade.…”
Section: Discussionsupporting
confidence: 92%
“…A study showed that the intestinaltype was more frequently CD44s-and CD44v6-positive than the diffuse-type tumor [15] , although the reactivity to these two antibodies did not correlate with histopathological and clinical prognostic factors in intestinal-type carcinoma [31] . More recently, Yamaguchi et al [16] found that the expression of CD44v6 protein was significantly higher in differentiated adenocarcinoma than in diffuse-type carcinoma. On the other hand, Saito et al [29] observed that CD44v6 appeared to play an important role in the invasion and metastasis of diffusetype gastric carcinoma, but not in that of intestinal-type gastric carcinoma, and also demonstrated a significant correlation between CD44v6 expression and poor prognosis of diffuse-type gastric carcinoma.…”
Section: Discussionmentioning
confidence: 98%
“…Joo et al [26,27] obtained almost the same results as ours. But Yamaguchi et al [28] tended to consider CD44v6 protein to have an important role in hematogenous metastasis of gastric carcinomas.…”
Section: A B C D E Fmentioning
confidence: 99%